Position
INCEPTIONR LLC in BridgeBio Pharma, Inc.
Back to the book · All holders of BBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$13.4K$76.49 → $74.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6K | $458.6K | — | — | — | 0.1% |
| Q1 2026 | 8.8K | $653.8K | $74.26 | −$13.4K | $208.6K | 0.2% |